pravastatin has been researched along with dalteparin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerensky, RA; Monroe, VS; Pepine, CJ; Rivera, E; Smith, KM | 1 |
| Dagklis, T; Girardi, G; Lefkou, E; Mamopoulos, A; Rousso, D; Vosnakis, C | 1 |
1 review(s) available for pravastatin and dalteparin
| Article | Year |
|---|---|
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; C-Reactive Protein; Coronary Artery Disease; Coronary Thrombosis; Disease Progression; Endothelium, Vascular; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Macrophages; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Randomized Controlled Trials as Topic; Secondary Prevention; Severity of Illness Index | 2003 |
1 other study(ies) available for pravastatin and dalteparin
| Article | Year |
|---|---|
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
Topics: Adult; Antiphospholipid Syndrome; Endothelium; Enoxaparin; Female; Fibrinolytic Agents; Gestational Age; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors; Tinzaparin; Uterine Artery | 2016 |